Stereotaxis, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Stereotaxis, Inc. on February 5, 2016, reporting an event that occurred on February 2, 2016. The filing addresses a critical regulatory status update regarding the company's listing on The NASDAQ Stock Market.
Key Financial Metrics
The filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on compliance with listing standards rather than operational financial performance.
Material Changes
On February 2, 2016, the company received a determination letter from the NASDAQ Listing Qualifications Staff stating that it failed to regain compliance with Listing Rule 5550(b)(2), the Market Value of Listed Securities (MVLS) Rule. The company failed to maintain the required minimum MVLS of $35 million for the 30 consecutive business days prior to the initial notification on August 5, 2015. Consequently, the company's securities are subject to delisting unless a hearing is requested.
Outlook, Risks, and Management Commentary
- Management Action: The company intends to timely request a hearing before the Nasdaq Listing Qualifications Panel to present its plan for achieving compliance.
- Immediate Effect: Requesting a hearing will automatically stay the delisting process pending the Panel's decision.
- Potential Extension: The Panel may grant an exception to continue listing for up to 180 calendar days from the determination letter date, extending through July 31, 2016.
- Risks: There is no assurance that the Panel will grant an extension or that the company will achieve compliance with the applicable listing requirements.
Key Facts for Investor Verification
- Verify the current market value of listed securities to assess the gap against the $35 million requirement.
- Confirm the status of the hearing request with the Nasdaq Listing Qualifications Panel.
- Monitor for any subsequent announcements regarding the Panel's decision on the extension request.
- Review the company's specific plan for achieving compliance as presented to the Panel.